DXCM:NGS-DexCom Inc. (USD)

EQUITY | Medical Devices | Nasdaq Global Select

Last Closing

USD 139.48

Change

-0.45 (-0.32)%

Market Cap

USD 5.94B

Volume

2.03M

Analyst Target

USD 475.06
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
ALGN Align Technology Inc

-1.48 (-0.48%)

USD 23.62B
BRKR Bruker Corporation

+0.38 (+0.47%)

USD 12.93B
SWAV Shockwave Medical Inc

+1.01 (+0.31%)

USD 12.34B
PODD Insulet Corporation

+2.02 (+1.23%)

USD 11.49B
MASI Masimo Corporation

+0.90 (+0.67%)

USD 7.14B
AXNX Axonics Modulation Technologie..

+0.15 (+0.23%)

USD 3.39B
IRTC iRhythm Technologies Inc

+0.64 (+0.58%)

USD 3.36B
QDEL Quidel Corporation

-0.05 (-0.13%)

USD 3.14B
LIVN LivaNova PLC

+0.43 (+0.78%)

USD 3.02B
IART Integra LifeSciences Holdings

-0.07 (-0.25%)

USD 2.64B

ETFs Containing DXCM

CYBG:LSE VanEck Bionic Engineering.. 10.19 % 0.00 %

+0.10 (+1.72%)

USD 6.05M
EKG First Trust Nasdaq Lux Di.. 9.62 % 0.00 %

+0.09 (+1.72%)

USD 2.33M
CIB0:XETRA VanEck Bionic Engineering.. 8.78 % 0.00 %

+0.09 (+1.72%)

USD 6.36M
EDOC:AU BetaShares Digital Health.. 8.40 % 0.00 %

-0.04 (1.72%)

N/A
SN5R:XETRA Global X Internet of Thin.. 6.97 % 0.00 %

+0.18 (+1.72%)

USD 3.06M
SNSG:LSE Global X Internet of Thin.. 6.90 % 0.00 %

+0.14 (+1.72%)

USD 2.98M
SANE 6.79 % 0.00 %

N/A

N/A
EDOC Global X Telemedicine & D.. 6.37 % 0.00 %

+0.09 (+1.72%)

USD 0.05B
CURE:XETRA VanEck Genomics and Healt.. 6.26 % 0.00 %

+0.24 (+1.72%)

USD 6.89M
EDOC:LSE Global X Telemedicine & D.. 5.98 % 0.00 %

+0.14 (+1.72%)

USD 5.32M
EDOG:LSE Global X Telemedicine & D.. 5.98 % 0.00 %

+0.13 (+1.72%)

USD 5.32M
FDHT 5.60 % 0.00 %

N/A

N/A
SNSR:SW Global X Internet of Thin.. 5.23 % 0.00 %

+0.08 (+1.72%)

USD 2.99M
DDOC:F Global X Telemedicine & D.. 4.76 % 0.00 %

+0.07 (+1.72%)

USD 5.32M
EDOC:SW Global X Telemedicine & D.. 4.76 % 0.00 %

+0.12 (+1.72%)

USD 4.92M
FDHT:XETRA Fidelity Digital Health U.. 4.18 % 0.00 %

+0.09 (+1.72%)

USD 4.79M
MEDI Harbor Health Care ETF 4.14 % 0.00 %

-0.11 (1.72%)

USD 0.01B
MID S&P Midcap 400 3.98 % 0.00 %

+0.50 (+1.72%)

USD 0.06B
UMDV:SW iShares US Medical Device.. 3.89 % 0.00 %

+0.03 (+1.72%)

USD 0.18B
CARK Castleark Large Growth ET.. 3.76 % 0.00 %

+0.59 (+1.72%)

USD 0.34B
AGNG Global X Aging Population.. 3.59 % 0.00 %

-0.11 (1.72%)

USD 0.06B
PFUT Putnam Sustainable Future.. 2.89 % 0.00 %

+0.19 (+1.72%)

USD 0.23B
MMLG First Trust Exchange-Trad.. 2.69 % 0.00 %

+0.37 (+1.72%)

USD 0.06B
QQXT First Trust NASDAQ-100 Ex.. 1.80 % 0.60 %

-0.04 (1.72%)

USD 0.15B
DTEC ALPS Disruptive Technolog.. 1.23 % 0.00 %

+0.69 (+1.72%)

USD 0.09B
BFIT 0.00 % 0.50 %

N/A

N/A
IHI iShares U.S. Medical Devi.. 0.00 % 0.43 %

+0.26 (+1.72%)

USD 5.55B
IWP iShares Russell Mid-Cap G.. 0.00 % 0.24 %

+0.52 (+1.72%)

USD 14.98B
JKH 0.00 % 0.30 %

N/A

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
GDNA 0.00 % 0.00 %

N/A

N/A
SLIM 0.00 % 0.50 %

N/A

N/A
SNSR Global X Internet of Thin.. 0.00 % 0.69 %

-0.05 (1.72%)

USD 0.29B
VO Vanguard Mid-Cap Index Fu.. 0.00 % 0.04 %

+0.57 (+1.72%)

USD 61.53B
VOT Vanguard Mid-Cap Growth I.. 0.00 % 0.07 %

+1.66 (+1.72%)

USD 12.34B
XSD2:LSE db x-trackers ShortDAX x2.. 0.00 % 0.00 %

-2.29 (1.72%)

USD 0.13B
DBPD:F Xtrackers - ShortDAX x2 D.. 0.00 % 0.00 %

-0.03 (1.72%)

USD 0.14B
DBPD:XETRA Xtrackers ShortDAX x2 Dai.. 0.00 % 0.00 %

-0.03 (1.72%)

USD 0.13B
DDOC:XETRA Global X Telemedicine & D.. 0.00 % 0.00 %

+0.15 (+1.72%)

USD 5.32M
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

+0.31 (+1.72%)

N/A
CVGB:LSE VanEck Smart Home Active .. 0.00 % 0.00 %

+0.16 (+1.72%)

USD 0.01B
CAVE:LSE VanEck Smart Home Active .. 0.00 % 0.00 %

+0.19 (+1.72%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.40% 73% C 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.40% 73% C 75% C
Trailing 12 Months  
Capital Gain 22.39% 80% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.39% 80% B- 74% C
Trailing 5 Years  
Capital Gain 368.45% 95% A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 368.45% 95% A 94% A
Average Annual (5 Year Horizon)  
Capital Gain 39.77% 84% B 89% A-
Dividend Return 39.77% 84% B 88% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 65.07% 47% F 25% F
Risk Adjusted Return 61.12% 95% A 88% B+
Market Capitalization 5.94B 100% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 103.24 20% 11%
Price/Book Ratio 24.86 7% 4%
Price / Cash Flow Ratio 68.59 4% 4%
Price/Free Cash Flow Ratio 55.96 6% 4%
Management Effectiveness  
Return on Equity 25.78% 97% 92%
Return on Invested Capital 9.97% 87% 79%
Return on Assets 6.41% 94% 89%
Debt to Equity Ratio 117.67% 25% 20%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.